Influence of pH on the Cytotoxic Activity of Inositol Hexakisphosphate (IP6) in Prostate Cancer

Objectives: In the present study, we investigated whether the pH of IP6 could influence its anti-tumoral activity in vitro. Methods: PC-3 cells were exposed to IP6 at pH 5, pH 7, and pH 12 and we evaluated the metabolic activity (WST-1 assay), cell proliferation (cell count), cell cycle distribution (FACS), and mitochondrial depolarization (JC-1 staining) in vitro. Results: Our results demonstrated that IP6 at pH 5 and pH 12 were more potent at lowering the metabolic activity of PC-3 cells than IP6 at pH 7. Treatment with IP6 at pH 12 also caused the greatest inhibition in cellular proliferation and accumulation of PC-3 cells in sub-G1. Finally, IP6 at pH 12 lead to a reduction in phospho-AKT and phospho-PDK1 and upregulated phospho-ERK. Conclusion: Together, our data strongly suggest that the pH of IP6 effectively modulates its anti-tumoral activity and should be reported in future studies.

• Publication year

  2011

• Venue

  Frontiers in Oncology

• Publication date

  2011-10-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3389/fonc.2011.00040PMID 22655245PMCID 3356122
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inositol hexaphosphate downregulates both constitutive and ligand‐induced mitogenic and cell survival signaling, and causes caspase‐mediated apoptotic death of human prostate carcinoma PC‐3 cells

  2010influential reference
• HOXA13 promotes cancer cell growth and predicts poor survival of patients with esophageal squamous cell carcinoma.

  2009cited by this paper
• Inositol hexaphosphate suppresses growth and induces apoptosis in prostate carcinoma cells in culture and nude mouse xenograft: PI3K-Akt pathway as potential target.

  2009influential reference
• p21/Cip1 and p27/Kip1 Are essential molecular targets of inositol hexaphosphate for its antitumor efficacy against prostate cancer.

  2009cited by this paper
• Chemopreventive Efficacy of Inositol Hexaphosphate against Prostate Tumor Growth and Progression in TRAMP Mice

  2008cited by this paper
• Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitors

  2008cited by this paper
• Protection Against Cancer by Dietary IP6 and Inositol

  2006influential reference
• Inositol hexaphosphate represses telomerase activity and translocates TERT from the nucleus in mouse and human prostate cancer cells via the deactivation of Akt and PKCalpha.

  2006cited by this paper
• Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo.

  2006cited by this paper
• Regulation of survivin by ErbB2 signaling: therapeutic implications for ErbB2-overexpressing breast cancers.

  2006cited by this paper
• An androgen‐independent androgen receptor function protects from inositol hexakisphosphate toxicity in the PC3/PC3(AR) prostate cancer cell lines

  2006cited by this paper
• Regulation of Blood Glucose by Hypothalamic Pyruvate Metabolism

  2005cited by this paper
• Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells.

  2004cited by this paper
• In Vivo Suppression of Hormone-Refractory Prostate Cancer Growth by Inositol Hexaphosphate

  2004cited by this paper
• Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer

  2004cited by this paper
• Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes.

  2003cited by this paper
• Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic.

  2003cited by this paper
• Rice-bran products: phytonutrients with potential applications in preventive and clinical medicine.

  2001cited by this paper
• The role of phytic acid in legumes: antinutrient or beneficial function?

  2000cited by this paper
• Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells.

  2000cited by this paper
• Inositol hexaphosphate (IP6) as an anti-neoplastic and lipid-lowering agent.

  1999cited by this paper
• Mitochondrial Depolarization Accompanies Cytochrome cRelease During Apoptosis in PC6 Cells*

  1999cited by this paper
• IP6: a novel anti-cancer agent.

  1997cited by this paper
• Synthesis and iron binding studies of myo-inositol 1,2,3-trisphosphate and (+/-)-myo-inositol 1,2-bisphosphate, and iron binding studies of all myo-inositol tetrakisphosphates.

  1996cited by this paper
• Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cells.

  1995cited by this paper
• Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.

  1993cited by this paper
• Inhibition of iron-catalysed hydroxyl radical formation by inositol polyphosphates: a possible physiological function for myo-inositol hexakisphosphate.

  1993cited by this paper
• Effect of deficiencies of selenium and vitamin E alone or in combination on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea.

  1991cited by this paper
• Phytic acid and minerals: effect on early markers of risk for mammary and colon carcinogenesis.

  1991cited by this paper
• Phytic acid. A natural antioxidant.

  1987cited by this paper

• Novel phospholipid-based Labrasol nanomicelles loaded with flavonoids for oral delivery with enhanced penetration and anti-brain tumor efficiency.

  2020cites this paper